Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly Diagnosed Chemotherapy Naive Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. The Observational ROADMAT-CAT-MM Study

被引：0
作者：
Fotiou, Despina [1 ]
Sergentanis, Theodoros [1 ]
Papageorgiou, Loula [2 ,3 ]
Gavriatopoulou, Maria [1 ]
Psaltopoulou, Theodora [1 ]
VanDreden, Patrick [2 ,3 ]
Larsen, Annette [2 ]
Elalamy, Ismail [2 ,3 ]
Kastritis, Efstathios [1 ]
Stamatelopoulos, Kimon [1 ]
Terpos, Evangelos [1 ]
Dimopoulos, Meletios [1 ]
Gerotziafas, Grigoris [2 ,3 ]
机构：
[1] Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] UPMC, Fac Med Pierre & Marie Curie, Canc Biol & Therapeut, INSERM,U938,IUC,Sorbonne Univ, Paris, France
[3] Hop Univ Est Parisien, Hop Tenon, AP HP, Serv Hematol Biol, Paris, France
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Multiple Myeloma; Cancer-associated thrombosis; Risk assessment model; Thromboprophylaxis;
D O I：
10.1016/j.clml.2018.07.121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-021
引用
收藏
页码：S235 / S236
页数：2
相关论文
共 4 条
  • [1] Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study
    Syrigos, Konstantinos
    Grapsa, Dimitra
    Sangare, Rabiatou
    Evmorfiadis, Ilias
    Larsen, Annette K.
    Van Dreden, Patrick
    Boura, Paraskevi
    Charpidou, Andriani
    Kotteas, Elias
    Sergentanis, Theodoros N.
    Elalamy, Ismail
    Falanga, Anna
    Gerotziafas, Grigoris T.
    ONCOLOGIST, 2018, 23 (11) : 1372 - 1381
  • [2] Treatment Resistance Risk in Patients with Newly Diagnosed Multiple Myeloma Is Associated with Blood Hypercoagulability: The ROADMAP-MM Study
    Gerotziafas, Grigorios T.
    Fotiou, Despina
    Sergentanis, Theodoros N.
    Papageorgiou, Loula
    Fareed, Jawed
    Falanga, Anna
    Sabbah, Michele
    Garderet, Laurent
    Terpos, Evangelos
    Elalamy, Ismail
    Van Dreden, Patrick
    Dimopoulos, Meletios A.
    HEMATO, 2022, 3 (01): : 188 - 203
  • [3] Derivation of Prediction Model for Treatment Failure Risk in Multiple Myeloma Patients Based on Biomarkers of Hypercoagulability. The Prospective Observational ROADMAP-MM-CAT Study
    Gerotziafas, Grigoris
    Fotiou, Despina
    Sergentanis, Theodoros
    Papageorgiou, Loula
    Rousseau, Aurelie
    Van Dreden, Patrick
    Elalamy, Ismail
    Larsen, Annette
    Falanga, Anna
    Terpos, Evangelos
    Mohty, Mohamad
    Dimopoulos, Meletios
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S323 - S323
  • [4] Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study
    Dimopoulos, Meletios A.
    Mateos, Maria-Victoria
    Richardson, Paul G.
    Schlag, Rudolf
    Khuageva, Nuriet K.
    Shpilberg, Ofer
    Kropff, Martin
    Spicka, Ivan
    Palumbo, Antonio
    Wu, Ka Lung
    Esseltine, Dixie-Lee
    Liu, Kevin
    Deraedt, William
    Cakana, Andrew
    van de Velde, Helgi
    San Miguel, Jesus F.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (01) : 23 - 31
1